跳至主要内容
临床试验/CTRI/2024/06/069098
CTRI/2024/06/069098尚未招募2 期

Combined effect of Amritaguggulu and Amritashadangam Kashayam in the management of Hyperuricemia a pre test post test design - NI

SILPA M R0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Participants without symptoms and with symptoms like pain and or tenderness of joint and
  • serum uric acid level greater than 6.8mg/dL to 12mg/dl in males and greater than 5.7mg/dL to 12mg/dl in females
  • will be included
  • 2.Participants aged between 30-60 years will be included

排除标准

  • 1.Participants with secondary Gout, pre diagnosed cases of Rheumatoid Arthritis.
  • 2.Participants taking other medication for hyperuricemia.
  • 3.Severe Systemic illness such as Chronic Kidney Disease, Diabetes Mellitus.
  • 4.Chronic Cardiac Disease.
  • 5.Pregnant women and lactating mother.
  • 6.Participants having completed any other trial with in past 6 months.
  • 7.Participants intaking alcohol

研究者

发起方
SILPA M R

相似试验